Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease
NCT05042206
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease Stage 3B
Chronic Kidney Disease stage4
Interventions
BIOLOGICAL:
Cellgram-CKD
Sponsor
Pharmicell Co., Ltd.